BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24442999)

  • 1. Complementary and alternative medicine use and disclosure amongst Australian radiotherapy patients.
    Hunter D; Oates R; Gawthrop J; Bishop M; Gill S
    Support Care Cancer; 2014 Jun; 22(6):1571-8. PubMed ID: 24442999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of complementary and alternative medical therapies (CAM) by patients attending a regional comprehensive cancer care centre.
    Wilkinson JM; Stevens MJ
    J Complement Integr Med; 2014 Jun; 11(2):139-45. PubMed ID: 24698828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.
    Yarney J; Donkor A; Opoku SY; Yarney L; Agyeman-Duah I; Abakah AC; Asampong E
    BMC Complement Altern Med; 2013 Jan; 13():16. PubMed ID: 23331546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementary and alternative medicine in radiation oncology : Survey of patients' attitudes.
    Lettner S; Kessel KA; Combs SE
    Strahlenther Onkol; 2017 May; 193(5):419-425. PubMed ID: 28130601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medicine: use and disclosure in radiation oncology community practice.
    Rausch SM; Winegardner F; Kruk KM; Phatak V; Wahner-Roedler DL; Bauer B; Vincent A
    Support Care Cancer; 2011 Apr; 19(4):521-9. PubMed ID: 20336329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary therapy use in metropolitan and regional Australian radiotherapy centres; do patients report effective outcomes?
    Hunter D; Marinakis C; Salisbury R; Cray A; Oates R
    Support Care Cancer; 2016 Apr; 24(4):1803-11. PubMed ID: 26446700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-physician communication about complementary and alternative medicine in a radiation oncology setting.
    Ge J; Fishman J; Vapiwala N; Li SQ; Desai K; Xie SX; Mao JJ
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e1-6. PubMed ID: 23040545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary and Alternative Medicine Use in Breast Cancer Patients at a Medical Center in Taiwan: A Cross-Sectional Study.
    Chin CY; Chen YH; Wu SC; Liu CT; Lee YF; Tsai MY
    Integr Cancer Ther; 2020; 19():1534735420983910. PubMed ID: 33372560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary and Alternative Medicine Use in Cancer Patients in Rural Australia.
    Sullivan A; Gilbar P; Curtain C
    Integr Cancer Ther; 2015 Jul; 14(4):350-8. PubMed ID: 25873293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary and Alternative Medicine: A Clinical Study in 1,016 Hematology/Oncology Patients.
    Hierl M; Pfirstinger J; Andreesen R; Holler E; Mayer S; Wolff D; Vogelhuber M
    Oncology; 2017; 93(3):157-163. PubMed ID: 28641281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of complementary and alternative medicine use amongst outpatients in Tokyo, Japan.
    Hori S; Mihaylov I; Vasconcelos JC; McCoubrie M
    BMC Complement Altern Med; 2008 Apr; 8():14. PubMed ID: 18433476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center.
    Judson PL; Abdallah R; Xiong Y; Ebbert J; Lancaster JM
    Integr Cancer Ther; 2017 Mar; 16(1):96-103. PubMed ID: 27444312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of complementary and alternative medicine among breast cancer patients in Hungary: A descriptive study.
    Sárváry A; Sárváry A
    Complement Ther Clin Pract; 2019 May; 35():195-200. PubMed ID: 31003658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
    Chrystal K; Allan S; Forgeson G; Isaacs R
    N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and Alternative Medicine Use at a Comprehensive Cancer Center.
    Luo Q; Asher GN
    Integr Cancer Ther; 2017 Mar; 16(1):104-109. PubMed ID: 27151586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.
    Bahall M
    BMC Complement Altern Med; 2017 Jun; 17(1):345. PubMed ID: 28666435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medicine (CAM) among hospitalised patients: reported use of CAM and reasons for use, CAM preferred during hospitalisation, and the socio-demographic determinants of CAM users.
    Shorofi SA
    Complement Ther Clin Pract; 2011 Nov; 17(4):199-205. PubMed ID: 21982133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary and alternative medicine practices among Asian radiotherapy patients.
    Wong LC; Chan E; Tay S; Lee KM; Back M
    Asia Pac J Clin Oncol; 2010 Dec; 6(4):357-63. PubMed ID: 21114786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine (CAM) among hospitalised patients: an Australian study.
    Shorofi SA; Arbon P
    Complement Ther Clin Pract; 2010 May; 16(2):86-91. PubMed ID: 20347839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine in sarcoma patients treated in an Italian sarcoma center.
    Longhi A; Setola E; Ferrari C; Carretta E
    J Cancer Res Ther; 2021; 17(2):516-522. PubMed ID: 34121701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.